fda warning letter glp-1 october 2025 On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a to Platinum Biologics LLC for marketing umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval Data Integrity : Key Lessons
Pay in 4 interest-free payments of $6.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3


















:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)







